InsiderTrades.com logo
Media Is Mocking Elon, But Wait Until They See This Demo
From Brownstone Research   |   Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.

VPT Insider Trading

Insider Ownership Percentage: 2.13%
Insider Buying (Last 12 Months): C$37,849.50
Insider Selling (Last 12 Months): C$0.00

VentriPoint Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at VentriPoint Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

VentriPoint Diagnostics Share Price & Price History

Current Price: C$0.10
Price Change: ▼ Price Decrease of -0.005 (-5.00%)
As of 12/12/2024 06:32 PM ET

This chart shows the closing price history over time for VPT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
First JFK… next Elon?
From Porter & Company   |   Ad
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.

VentriPoint Diagnostics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/2/2024Hugh MacnaughtDirectorBuy20,000C$0.22C$4,420.00
4/26/2024Robert HodgkinsonDirectorBuy4,500C$0.21C$945.00
4/24/2024Robert HodgkinsonDirectorBuy21,000C$0.21C$4,410.00
4/22/2024Robert HodgkinsonDirectorBuy75,000C$0.21C$15,900.00
4/18/2024Robert HodgkinsonDirectorBuy36,500C$0.21C$7,774.50
4/12/2024Hugh MacnaughtDirectorBuy20,000C$0.22C$4,400.00
See Full Table
WARNING: “Buffett Indicator” flashing for first time in 50 years
From Behind the Markets   |   Ad
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.
Take these 4 steps today to protect your retirement NOW

SEC Filings (Institutional Ownership Changes) for VentriPoint Diagnostics (CVE:VPT)

VentriPoint Diagnostics logo
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
Read More on VentriPoint Diagnostics

Today's Range

Now: C$0.10
Low: C$0.10
High: C$0.11

50 Day Range

MA: C$0.14
Low: C$0.09
High: C$0.19

52 Week Range

Now: C$0.10
Low: C$0.09
High: C$0.36

Volume

78,502 shs

Average Volume

111,499 shs

Market Capitalization

C$14.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.39

Who are the company insiders with the largest holdings of VentriPoint Diagnostics?

VentriPoint Diagnostics' top insider shareholders include:
  1. Hugh Macnaught (Director)
  2. Robert Hodgkinson (Director)
Learn More about top insider investors at VentriPoint Diagnostics.
Media Is Mocking Elon, But Wait Until They See This Demo
From Brownstone Research   |   Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.